Marshall BioResources
Active — Near MonopolyUSDA AWA Violations
Marshall BioResources has been cited for more than 20 Animal Welfare Act violations since 2007, documented by USDA APHIS inspectors and compiled by Rise for Animals. The violations span nearly two decades of inspections at the North Rose, New York facility.
The Enforcement Gap
The contrast between Marshall's enforcement history and that of other facilities raises questions about USDA inspection consistency:
Copenhagen Route Investigation (2023)
A 2023 investigative exposé documented that over 6,000 beagles had been transported on SAS passenger flights from Marshall's US facility through Copenhagen Airport, then distributed to laboratories in seven European countries.
- 6,000+ beagles documented as shipped via this single route
- Dogs traveled as cargo on SAS passenger planes
- Route: North Rose, NY → Copenhagen → UK, Italy, Germany, Netherlands, Spain, Belgium, France
- Route disrupted following public exposure — no documented shipments afterward
- Marshall's alternative European shipping routes remain unknown
PETA Investigation
PETA has conducted investigations documenting conditions at Marshall and at Liberty Research, identified as a Marshall-linked facility. Investigation details and published materials are available through PETA's public reporting.
Genetic Evidence
A 2024 study published in Springer Immunogenetics documented that Marshall's colony beagles have restricted DLA class II immune diversity compared to pet beagles. This finding has scientific and regulatory implications:
- Vaccine and immunology study results from Marshall dogs may not generalize to pet beagles or other breeds
- Colony-specific pharmacogenomics (e.g., CYP2D15 polymorphisms) mean drug safety profiles can vary depending on which colony tested them
- Mean inbreeding coefficient (F_ROH) ~0.031 — structured lineage breeding, not close inbreeding
- Raises questions about the scientific validity of extrapolating from these genetically narrow populations